Get the Stockscreener App
56.83
1.90%
1.06
Pre-market:
56.64
-0.19
-0.33%
Overview
News
Price History
Option Chain
Financials
Why CVS Down?
Discussions
Forecast
Stock Split
Dividend History
Cvs Health Corp stock is traded at $56.83, with a volume of 11.17M.
It is up +1.90% in the last 24 hours and down -5.82% over the past month.
CVS Health offers a diverse set of healthcare services. Its roots are in its retail pharmacy operations, where it operates over 9,000 stores primarily in the us. CVS is also a large pharmacy benefit manager (acquired through Caremark), processing about 2 billion adjusted claims annually. It also operates a top-tier health insurer (acquired through Aetna) where it serves about 26 million medical members. The company's recent acquisition of Oak Street adds primary care services to the mix, which could have significant synergies with all its existing business lines.
See More
Previous Close:
$55.77
Open:
$56.25
24h Volume:
11.17M
Relative Volume:
1.06
Market Cap:
$71.44B
Revenue:
$368.91B
Net Income/Loss:
$5.02B
P/E Ratio:
8.5716
EPS:
6.63
Net Cash Flow:
$1.69B
1W Performance:
+4.72%
1M Performance:
-5.82%
6M Performance:
-0.99%
1Y Performance:
-16.74%
1-Day Range:
$56.00
$57.67
1-Week Range:
$52.71
$57.67
52-Week Range:
$52.71
$83.25
Cvs Health Corp Stock (CVS) Company Profile
Name
Cvs Health Corp
Sector
Industry
Phone
(401) 765-1500
Address
ONE CVS DR., WOONSOCKET
Compare CVS with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
| CVS | 56.83 | 71.44B | 368.91B | 5.02B | 1.69B | 6.63 |
| UNH | 600.50 | 543.90B | 389.07B | 14.32B | 13.10B | 23.04 |
| ELV | 397.48 | 91.77B | 174.02B | 6.42B | 871.00M | 25.47 |
| CI | 323.39 | 89.04B | 229.75B | 3.04B | 5.18B | 17.73 |
| HUM | 293.97 | 34.80B | 115.01B | 1.36B | -4.34B | 24.12 |
Cvs Health Corp Stock (CVS) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-10-24 | Upgrade | Barclays | Equal Weight → Overweight |
| Oct-04-24 | Upgrade | TD Cowen | Hold → Buy |
| May-30-24 | Initiated | Robert W. Baird | Neutral |
| May-07-24 | Downgrade | TD Cowen | Buy → Hold |
| May-02-24 | Downgrade | UBS | Buy → Neutral |
| May-01-24 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| May-01-24 | Downgrade | Leerink Partners | Outperform → Market Perform |
| Mar-06-24 | Initiated | Barclays | Equal Weight |
| Feb-26-24 | Initiated | Leerink Partners | Outperform |
| Dec-22-23 | Initiated | HSBC Securities | Buy |
| Sep-19-23 | Upgrade | Evercore ISI | In-line → Outperform |
| Sep-12-23 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| Aug-18-23 | Downgrade | Edward Jones | Buy → Hold |
| May-26-23 | Initiated | Piper Sandler | Overweight |
| Apr-21-23 | Initiated | Cantor Fitzgerald | Overweight |
| Jan-03-23 | Downgrade | Evercore ISI | Outperform → In-line |
| Nov-23-22 | Resumed | Morgan Stanley | Overweight |
| Jun-17-22 | Initiated | Loop Capital | Buy |
| May-27-22 | Downgrade | Bernstein | Outperform → Mkt Perform |
| Mar-29-22 | Downgrade | Deutsche Bank | Buy → Hold |
| Feb-11-22 | Downgrade | Raymond James | Strong Buy → Outperform |
| Dec-14-21 | Initiated | Goldman | Buy |
| Dec-01-21 | Initiated | Seaport Research Partners | Buy |
| May-19-21 | Initiated | Wells Fargo | Equal Weight |
| Mar-17-21 | Downgrade | Guggenheim | Buy → Neutral |
| Jan-08-21 | Upgrade | Jefferies | Hold → Buy |
| Sep-17-20 | Initiated | Piper Sandler | Overweight |
| Jul-01-20 | Initiated | SVB Leerink | Mkt Perform |
| May-14-20 | Upgrade | Credit Suisse | Neutral → Outperform |
| Sep-27-19 | Resumed | RBC Capital Mkts | Outperform |
| Sep-12-19 | Initiated | Deutsche Bank | Buy |
| Jun-05-19 | Upgrade | Standpoint Research | Hold → Buy |
| Apr-29-19 | Downgrade | Credit Suisse | Outperform → Neutral |
| Apr-18-19 | Initiated | Guggenheim | Buy |
| Apr-15-19 | Downgrade | Oppenheimer | Outperform → Perform |
| Apr-10-19 | Reiterated | BofA/Merrill | Buy |
| Mar-13-19 | Initiated | Bernstein | Outperform |
| Feb-20-19 | Downgrade | Wells Fargo | Outperform → Market Perform |
| Jan-17-19 | Initiated | UBS | Buy |
| Dec-18-18 | Initiated | Barclays | Overweight |
| Nov-29-18 | Resumed | Goldman | Neutral |
| Nov-28-18 | Initiated | Evercore ISI | Outperform |
| Oct-26-18 | Resumed | Wolfe Research | Peer Perform |
| Jul-09-18 | Upgrade | Citigroup | Neutral → Buy |
| Feb-27-18 | Resumed | BofA/Merrill | Buy |
| Feb-13-18 | Reiterated | Citigroup | Neutral |
View All
Cvs Health Corp Stock (CVS) Latest News
CVS Health Co. (NYSE:CVS) Shares Purchased by Advisors Asset Management Inc. - MarketBeat
PNC Financial Services Group Inc. Has $46.82 Million Stake in CVS Health Co. (NYSE:CVS) - MarketBeat
61,838 Shares in CVS Health Co. (NYSE:CVS) Acquired by B. Metzler seel. Sohn & Co. Holding AG - MarketBeat
CVS Can't Dodge Proposed Action Over 'Non-Drowsy' Claims - Law360
CVS Health Corp. stock outperforms competitors on strong trading day - MarketWatch
CVS Hit With California Class Action After Minute Clinic Layoffs - Bloomberg Law
Big Pharma's Pharmacy-Benefit Managers Accuse FTC of Overreach In Effort to Reshape Drug Rebate System - Benzinga
Payer Roundup—CVS insider trading scandal; DOJ examining PBMs - Fierce healthcare
CVS Health bulks its board up to 16 members, adds hedge fund CEO - MSN
Is CVS Health Stock an Underrated Buy? - Yahoo! Voices
New CEO at CVS begins to build his team with a goal of reviving the struggling health care giant - MSN
How GC-of-Year Sam Khichi Has Helped CVS Barrel Through Challenges - Law.com
New York State Aims to Rein In Pharmacy Plans With New Rules - Bloomberg
Leerink Partnrs Has Positive View of CVS Health Q2 Earnings - MarketBeat
CVS Health Co. (NYSE:CVS) Shares Bought by Meeder Asset Management Inc. - MarketBeat
Bear of the Day: CVS Health (CVS) - Yahoo Finance
MAI Capital Management Trims Stock Position in CVS Health Co. (NYSE:CVS) - MarketBeat
Oak Street Co-Founder Exiting CVS - Healthcare Innovation
CVS Health Corp. stock underperforms Tuesday when compared to competitors - MarketWatch
CVS added Glenview’s Robbins to board under activist pressure - The Boston Globe
CVS makes deal with Glenview Capital, adds four board seats - Yahoo Finance
CVS continues executive leadership shakeup - The Business Journals
CVS, Cigna, UnitedHealth Sue to Nix FTC Case on Insulin Cost (1) - Bloomberg Law
Aetna Better Health of Illinois introduces same-day pharmacy delivery to members - Drug Store News
Leerink Partnrs Reduces Earnings Estimates for CVS Health - MarketBeat
Wells Fargo upgrades CVS Health to Overweight, ups price target to $66 - Yahoo Finance
Quest Partners LLC Invests $1.83 Million in CVS Health Co. (NYSE:CVS) - MarketBeat
CVS adds four new board members in deal with Glenview as CEO pursues a turnaround - Blue Water Healthy Living
Wachtell-Led CVS Adds Glenview CEO, Others To Board - Law360
Activist shareholder Glenview gains CVS board seat - The Business Journals
CVS Health Stock Is Moving Higher Monday: What's Going On? - Benzinga
Bear Of The Day: CVS Health (CVS) - Barchart
CVS Expands Board Amid Investor Pressure, Adds Glenview CEO and Industry Experts - Yahoo Finance
CVS Health names four new board members in deal with activist investor Glenview Capital - Yahoo! Voices
CVS Adds Glenview’s Robbins to Board Under Activist Pressure - Yahoo Finance
CVS Adds Glenview’s Robbins to Board Under Activist Pressure (2) - Bloomberg Law
CVS Health adds 4 board members from hedge fund - Providence Business News
CVS Health Adds Four New Board Members - Inkl
Activist investor Glenview secures 4 board seats at CVS Health - Financial Times
CVS adds four new board members in deal with Glenview Capital - MSN
CVS adds Glenview Capital Management founder to board - Modern Healthcare
CVS adds four new board members in deal with Glenview as CEO pursues a turnaround By Reuters - Investing.com
CVS Health (NYSE:CVS) Upgraded by Wells Fargo & Company to "Overweight" Rating - MarketBeat
CVS strikes deal with activist Glenview Capital for four board seats - CNBC
CVS Health Corporation (CVS) Expands Board and Enhances Leadersh - GuruFocus.com
CVS Health gains as board grows on deal with activist investor Glenview - Proactive Investors UK
Short Interest in CVS Health Co. (NYSE:CVS) Increases By 5.0% - MarketBeat
AMG National Trust Bank Has $7.17 Million Stock Holdings in CVS Health Co. (NYSE:CVS) - MarketBeat
11,030 Shares in CVS Health Co. (NYSE:CVS) Purchased by Aljian Capital Management LLC - MarketBeat
CVS Health Strengthens Board with Four Strategic Appointments After Glenview Talks | CVS Stock News - StockTitan
Cvs Health Corp Stock (CVS) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.28%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):